Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	135.04	145.42	53.51	-21.15	-44.88	-42.04
Depreciation & Amortization	17.21	13.96	6.55	2.85	1.86	1.22
Loss (Gain) From Sale of Investments	-5.34	-2.89	-8.86	-2.47	-0	0.01
Stock-Based Compensation	119.39	130.26	116.01	82.47	51.97	26.48
Provision & Write-off of Bad Debts	0.2	0.2	-0.77	1.61	-0.06	-
Other Operating Activities	-72.07	-82.59	1.52	2.13	0.88	1.07
Change in Accounts Receivable	34.3	-26.23	-2.6	-30.22	-27.02	-9.24
Change in Inventory	-48.82	-65.18	-46.23	-22	5.35	-8.75
Change in Accounts Payable	-22.26	-3.75	0.6	9.3	14.36	4.78
Change in Other Net Operating Assets	-0.57	7.77	10.52	2.14	9.13	6.36
Operating Cash Flow	157.07	116.98	130.25	24.65	11.57	-20.12
Operating Cash Flow Growth	33.74%	-10.19%	428.32%	113.09%	-	-

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-39.98	-38.5	-39.12	-23.63	-9.1	-4.67
Investment in Securities	8.72	59.95	-74	-271.19	-10.5	33.81
Investing Cash Flow	-31.26	21.45	-113.12	-294.82	-19.6	29.14

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Long-Term Debt Repaid	-	-	-	-	-24.5	-
Net Debt Issued (Repaid)	-	-	-	-	-24.5	-
Issuance of Common Stock	5.45	14.61	27.77	31.11	259.62	14.95
Repurchase of Common Stock	-110.41	-198.06	-80.17	-17.16	-0.04	-
Financing Cash Flow	-104.96	-183.45	-52.39	13.95	235.08	14.95

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Foreign Exchange Rate Adjustments	-0.02	-0.31	-0.12	0.16	0.08	-0.02
Net Cash Flow	20.83	-45.34	-35.39	-256.06	227.13	23.95

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	117.09	78.48	91.12	1.02	2.47	-24.79
Free Cash Flow Growth	37.74%	-13.88%	8798.73%	-58.59%	-	-
Free Cash Flow Margin	13.03%	8.61%	11.35%	0.16%	0.61%	-10.62%
Free Cash Flow Per Share	3.99	2.64	2.98	0.04	0.09	-0.91
Levered Free Cash Flow	94.64	54.5	62.72	0.03	17.43	-10.69
Unlevered Free Cash Flow	94.72	54.59	62.73	0.03	18.48	-9.36

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	0.14	0.14	0.02	-	2.32	1.89
Change in Working Capital	-37.35	-87.38	-37.71	-40.78	1.81	-6.86

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error